A detailed history of Boothbay Fund Management, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 30,779 shares of MIST stock, worth $56,941. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,779
Previous 30,779 -0.0%
Holding current value
$56,941
Previous $40,000 15.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.4 - $2.2 $4,467 - $7,020
3,191 Added 11.57%
30,779 $55,000
Q3 2023

Nov 14, 2023

BUY
$2.68 - $3.69 $6,464 - $8,900
2,412 Added 9.58%
27,588 $85,000
Q4 2022

Feb 14, 2023

SELL
$3.53 - $9.5 $171,473 - $461,472
-48,576 Reduced 65.86%
25,176 $99,000
Q3 2022

Nov 14, 2022

SELL
$5.86 - $9.43 $344,269 - $554,003
-58,749 Reduced 44.34%
73,752 $678,000
Q2 2022

Aug 15, 2022

SELL
$5.13 - $7.37 $265,205 - $381,006
-51,697 Reduced 28.07%
132,501 $815,000
Q1 2022

May 16, 2022

BUY
$4.1 - $8.24 $39,913 - $80,216
9,735 Added 5.58%
184,198 $1.18 Million
Q3 2021

Nov 15, 2021

SELL
$5.28 - $6.29 $265,557 - $316,355
-50,295 Reduced 22.38%
174,463 $996,000
Q2 2021

Aug 16, 2021

BUY
$5.22 - $6.11 $85,743 - $100,362
16,426 Added 7.88%
224,758 $1.24 Million
Q4 2020

Feb 12, 2021

BUY
$5.57 - $7.66 $53,605 - $73,719
9,624 Added 4.84%
208,332 $1.4 Million
Q3 2020

Nov 16, 2020

BUY
$3.34 - $9.8 $504,032 - $1.48 Million
150,908 Added 315.71%
198,708 $1.46 Million
Q2 2020

Aug 14, 2020

BUY
$1.77 - $4.56 $84,606 - $217,967
47,800 New
47,800 $181,000

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $55.5M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.